Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 3/20 | 0.42 |
| ▸ | FNTB | P49356 | 3/20 | 0.42 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL303333 | 0.98 | NOD1 (0.49) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL303334 | 0.98 | NOD1 (0.49) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL1147839 | 0.98 | NOD1 (0.49) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL5087526 | 0.97 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL5087530 | 0.97 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL25411986 | 0.97 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL462399 | 0.97 | NOD1 (0.48) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL9341321 | 0.97 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL9341319 | 0.97 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BLMNA | |
| SCHEMBL7765496 | 0.97 | NOD1 (0.51) | NOD1FNTAFNTBPGGT1BLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120065394-A1 | Corrosion Inhibitors Having Increased Biodegradability and Reduced Toxicity | CLARIANT FINANCE (BVI) LIMITED (VG) | 2012-03-15 | — | — | US | disclosed |
| US-20100234592-A1 | Corrosion Inhibitors Having Increased Biodegradability and Reduced Toxicity | CLARIANT FINANCE (BVI) LTD. (VG) | 2010-09-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100234592-A1 | Corrosion Inhibitors Having Increased Biodegradability and Reduced Toxicity | C5, C9, CYP1A1 | NOD1 1223/4885FNTA 4563/4885FNTB 3985/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.